Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 528 participants.
Also called NCT05257824
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 528 participants
- Sponsor
- Registry
-
NCT05257824
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT05257824. Randomized; no masking; primary purpose treatment. Start 2022-06-23 (actual); primary completion 2025-12-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling
- Condition
- Aneurysm Cerebral
- Condition
- Endovascular Procedures
- Intervention (Drug)
- Aspirin 100mg
- Intervention (Drug)
- Clopidogrel 75mg
- Lead sponsor
- Seoul National University Bundang Hospital
- Collaborator
- Pusan National University Yangsan Hospital
- Collaborator
- Keimyung University Dongsan Medical Center
- Collaborator
- Uijeongbu St. Mary's Hospital
- Collaborator
- Chungnam National University Sejong Hospital
- Collaborator
- Soonchunhyang University Hospital
- Collaborator
- Asan Medical Center
- Collaborator
- Gangnam Severance Hospital, Yonsei University College of Medicine
Record details
- Record id
cardio:ct-nct05257824- Content hash
9704d31085aed916dc1c8610e75261804c03ddda2e30465f010723da2f9f46c0